Regulatory

Jul 06, 2016
It's time for new pharma strategies to combat deadly drug-resistant infections, writes Jil Wechsler.
Jul 05, 2016
The UK's Brexit vote has unleashed turbulence in Europe — not least on its pharma sector. Reflector reports.
Jul 01, 2016
Leela Barham looks at the implications for the UK industry in the aftermath of last week's vote for Brexit.
Jun 30, 2016
FDA's Brenda Stodart outlines the services of the Agency's Small Business and Industry Assistance (SBIA) Program.
Jun 22, 2016
Highly skilled pharma staff are spending too much time on the routine updating of product information. Technology can free them, writes Dr. Jutta Hohenhörst.
Jun 21, 2016
Rapid growth in Medicare spending on prescription drugs is prompting a leading advisory group to recommend significant revisions in how the government pays for medicines under Part D and Part B
Jun 15, 2016
Despite enthusiasm from payers and pharma companies for innovative drug reimbursement strategies linked to positive patient responses, negotiating such deals is no easy business.
Jun 10, 2016
Sharing un-redacted inspection reports between FDA and EMA may reduce duplicate inspections of facilities.
Jun 09, 2016
Radicals who wield real power at the EMA have gone public with their thinking about the role of regulators in the economic aspects of medicines provision.
Jun 06, 2016
There’s a stampede to relate prices to broader health benefits, but little consensus on how to do so, writes Jill Wechsler.
native1_300x100
lorem ipsum